ALOGLIPTIN

ALOGLIPTIN was reported 3417 times

ALOGLIPTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BISALBUMINAEMIA 2 0.6667
1 LUMBOSACRAL RADICULOPLEXUS NEUROPATHY 7 0.1250
2 SPONDYLOLYSIS 8 0.0426
3 APPLICATION SITE HAEMATOMA 6 0.0328
4 MENINGITIS FUNGAL 5 0.0213
5 SILENT THYROIDITIS 3 0.0208
6 HYPERINSULINISM 2 0.0187
7 LIVER FUNCTION TEST 2 0.0171
8 INCISION SITE INFLAMMATION 2 0.0169
9 HYPOGLYCAEMIC ENCEPHALOPATHY 6 0.0154
10 PSEUDOHYPONATRAEMIA 2 0.0146
11 LEUKAEMIC INFILTRATION 2 0.0143
12 PEMPHIGOID 102 0.0135
13 THROMBOTIC CEREBRAL INFARCTION 5 0.0133
14 LARGE INTESTINAL POLYPECTOMY 2 0.0121
15 INTRA-OCULAR INJECTION COMPLICATION 2 0.0088
16 TONSIL CANCER 7 0.0087
17 OESOPHAGEAL SQUAMOUS CELL CARCINOMA 2 0.0082
18 POSTMORTEM BLOOD DRUG LEVEL INCREASED 3 0.0080
19 DIABETIC KETOSIS 3 0.0079
20 GALLBLADDER POLYP 6 0.0076
21 ASBESTOSIS 2 0.0071
22 HEPATIC CANCER RECURRENT 2 0.0070
23 DIABETIC GANGRENE 2 0.0070
24 PUTAMEN HAEMORRHAGE 2 0.0070
25 IMMUNOGLOBULIN G4 RELATED DISEASE 2 0.0063
26 DOUBLE STRANDED DNA ANTIBODY POSITIVE 2 0.0061
27 GASTROENTERITIS BACTERIAL 2 0.0061
28 GENITAL INFECTION 2 0.0061
29 BILE DUCT CANCER 7 0.0059
30 PNEUMONIA INFLUENZAL 7 0.0059
31 THALAMUS HAEMORRHAGE 5 0.0057
32 HAEMORRHAGIC CEREBRAL INFARCTION 4 0.0057
33 PORTAL VENOUS GAS 2 0.0055
34 HYPERAMYLASAEMIA 3 0.0055
35 HYPERMETROPIA 5 0.0053
36 BLOOD KETONE BODY INCREASED 4 0.0051
37 FULMINANT TYPE 1 DIABETES MELLITUS 5 0.0048
38 OCULOMUCOCUTANEOUS SYNDROME 2 0.0047
39 INFLUENZA A VIRUS TEST POSITIVE 2 0.0046
40 SMALL INTESTINE ULCER 3 0.0046
41 EUGLYCAEMIC DIABETIC KETOACIDOSIS 19 0.0046
42 NEUROSIS 2 0.0044
43 PROTEIN URINE 4 0.0044
44 IMMUNE-MEDIATED NEPHRITIS 2 0.0043
45 BLOOD CHOLESTEROL 2 0.0042
46 UPPER RESPIRATORY TRACT INFLAMMATION 5 0.0042
47 BLOOD CORTICOTROPHIN DECREASED 2 0.0041
48 DIABETIC RETINAL OEDEMA 2 0.0039
49 CHANGE OF BOWEL HABIT 8 0.0039
50 LYMPHOCYTE STIMULATION TEST POSITIVE 3 0.0037
51 CHRONIC HEPATITIS 3 0.0037
52 KETOSIS 4 0.0037
53 HYPOREFLEXIA 7 0.0036
54 DIABETIC NEPHROPATHY 8 0.0036
55 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0036
56 JOINT LOCK 10 0.0035
57 APTYALISM 3 0.0035
58 MECHANICAL ILEUS 2 0.0035
59 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 2 0.0034
60 IRREGULAR BREATHING 2 0.0034
61 COCCYDYNIA 5 0.0034
62 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 2 0.0032
63 HYPOGLYCAEMIC COMA 9 0.0031
64 HEART DISEASE CONGENITAL 11 0.0031
65 HEAT ILLNESS 2 0.0030
66 POST PROCEDURAL DISCHARGE 2 0.0030
67 CEREBRAL INFARCTION 72 0.0029
68 TRIGGER FINGER 12 0.0029
69 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
70 JUDGEMENT IMPAIRED 4 0.0028
71 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
72 BLOOD IRON INCREASED 5 0.0027
73 MICROALBUMINURIA 2 0.0026
74 SERONEGATIVE ARTHRITIS 3 0.0026
75 PNEUMOCYSTIS JIROVECII INFECTION 3 0.0025
76 ORGASM ABNORMAL 2 0.0025
77 ERYTHEMA MULTIFORME 23 0.0025
78 KETONURIA 2 0.0025
79 PNEUMATOSIS INTESTINALIS 7 0.0025
80 DUODENAL ULCER HAEMORRHAGE 7 0.0024
81 DIABETIC NEUROPATHY 12 0.0024
82 MICROCYTIC ANAEMIA 5 0.0024
83 METABOLIC ENCEPHALOPATHY 7 0.0023
84 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
85 ARTERIAL STENOSIS 2 0.0023
86 NECROTISING FASCIITIS 8 0.0023
87 ANION GAP INCREASED 3 0.0022
88 HYPERURICAEMIA 9 0.0022
89 DIABETIC KETOACIDOSIS 52 0.0022
90 BODY TEMPERATURE DECREASED 21 0.0021
91 MYOPIA 5 0.0021
92 PANCREATITIS ACUTE 47 0.0021
93 APLASIA PURE RED CELL 7 0.0020
94 CHOLANGIOCARCINOMA 3 0.0020
95 ACQUIRED HAEMOPHILIA 2 0.0020
96 CORONARY ARTERY STENOSIS 10 0.0020
97 AUTONOMIC NEUROPATHY 2 0.0020
98 NEPHROGENIC ANAEMIA 9 0.0019
99 URINE KETONE BODY PRESENT 3 0.0019
100 CARDIAC FAILURE CHRONIC 8 0.0019
101 RETINOPATHY 7 0.0019
102 PANCREATIC MASS 2 0.0019
103 RADIATION PNEUMONITIS 4 0.0019
104 OESOPHAGEAL VARICES HAEMORRHAGE 4 0.0018
105 HEPATOCELLULAR CARCINOMA 14 0.0018
106 ACARODERMATITIS 2 0.0018
107 ENTERITIS INFECTIOUS 3 0.0018
108 BLADDER NEOPLASM 3 0.0018
109 CACHEXIA 9 0.0017
110 INFECTION REACTIVATION 2 0.0017
111 PANCREATITIS NECROTISING 4 0.0017
112 PAPILLARY THYROID CANCER 3 0.0017
113 HYPOPITUITARISM 3 0.0017
114 EXTREMITY NECROSIS 3 0.0017
115 GROIN ABSCESS 2 0.0017
116 CHRONIC RESPIRATORY FAILURE 2 0.0017
117 BONE MARROW DISORDER 5 0.0017
118 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
119 DUODENITIS 5 0.0016
120 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
121 PANCREATIC NEOPLASM 2 0.0016
122 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
123 RENAL ATROPHY 2 0.0016
124 FEMORAL NECK FRACTURE 8 0.0016
125 PORTAL VEIN THROMBOSIS 5 0.0015
126 PYELONEPHRITIS ACUTE 3 0.0015
127 OCCULT BLOOD POSITIVE 3 0.0015
128 DRUG ERUPTION 27 0.0015
129 HYPOGLYCAEMIC UNCONSCIOUSNESS 3 0.0015
130 LACTIC ACIDOSIS 49 0.0015
131 INTERSTITIAL LUNG DISEASE 73 0.0015
132 GASTROINTESTINAL STROMAL TUMOUR 4 0.0015
133 SMALL INTESTINAL HAEMORRHAGE 3 0.0015
134 SUDDEN HEARING LOSS 3 0.0015
135 GLYCOSURIA 2 0.0015
136 DIABETIC RETINOPATHY 5 0.0015
137 INSULIN RESISTANCE 3 0.0014
138 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
139 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
140 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
141 HEPATIC PAIN 6 0.0014
142 CEREBELLAR HAEMORRHAGE 2 0.0014
143 POST HERPETIC NEURALGIA 2 0.0014
144 DYSLIPIDAEMIA 7 0.0014
145 PULMONARY PAIN 4 0.0014
146 GALLBLADDER CANCER 2 0.0014
147 BILIARY DILATATION 2 0.0014
148 AMYLASE INCREASED 5 0.0014
149 HYPOPHOSPHATAEMIA 10 0.0014
150 CARDIAC FAILURE ACUTE 9 0.0013
151 ACUTE CORONARY SYNDROME 11 0.0013
152 MARASMUS 2 0.0013
153 COMMUNICATION DISORDER 5 0.0013
154 RECTAL CANCER 4 0.0013
155 CALCULUS URINARY 2 0.0013
156 HYPOGLYCAEMIA 63 0.0013
157 HAEMOLYSIS 10 0.0013
158 COLON CANCER 19 0.0013
159 MEGACOLON 2 0.0013
160 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
161 PANCREATITIS CHRONIC 3 0.0013
162 VOLVULUS 3 0.0013
163 FAECAL CALPROTECTIN INCREASED 4 0.0013
164 LACUNAR INFARCTION 3 0.0013
165 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
166 BRONCHITIS CHRONIC 3 0.0012
167 SUDDEN DEATH 13 0.0012
168 HAEMOLYTIC ANAEMIA 11 0.0012
169 MOUTH SWELLING 7 0.0012
170 ENTEROCOLITIS 7 0.0012
171 INFLAMMATORY MARKER INCREASED 6 0.0012
172 ABDOMINAL TENDERNESS 6 0.0012
173 HYPERPARATHYROIDISM SECONDARY 3 0.0012
174 CEREBELLAR INFARCTION 2 0.0012
175 EXPOSURE TO SARS-COV-2 2 0.0012
176 ABNORMAL LOSS OF WEIGHT 8 0.0012
177 BLOOD PH DECREASED 2 0.0012
178 LARGE INTESTINE POLYP 8 0.0012
179 PYELONEPHRITIS 10 0.0012
180 HEPATIC FUNCTION ABNORMAL 43 0.0012
181 URINE OUTPUT INCREASED 3 0.0011
182 CAROTID ARTERY STENOSIS 4 0.0011
183 LUNG OPACITY 3 0.0011
184 EMBOLIC STROKE 4 0.0011
185 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
186 RHINITIS ALLERGIC 5 0.0011
187 AORTIC VALVE STENOSIS 2 0.0011
188 APPARENT DEATH 4 0.0011
189 GLYCOSYLATED HAEMOGLOBIN INCREASED 28 0.0011
190 BLOOD HIV RNA INCREASED 2 0.0011
191 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
192 CHOLECYSTITIS 13 0.0011
193 PNEUMONIA KLEBSIELLA 2 0.0011
194 VITREOUS HAEMORRHAGE 3 0.0011
195 GASTRIC ULCER HAEMORRHAGE 6 0.0011
196 LUNG CONSOLIDATION 3 0.0011
197 BLOOD BICARBONATE DECREASED 2 0.0011
198 APPETITE DISORDER 7 0.0011
199 ILEUS 13 0.0010
200 BREAST MASS 7 0.0010
201 BLOOD URIC ACID INCREASED 6 0.0010
202 DIFFUSE LARGE B-CELL LYMPHOMA 8 0.0010
203 COLITIS ISCHAEMIC 7 0.0010
204 HAEMOTHORAX 3 0.0010
205 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
206 POLYDIPSIA 4 0.0010
207 ATYPICAL PNEUMONIA 3 0.0010
208 PANCREATITIS 53 0.0010
209 CIRCULATORY COLLAPSE 17 0.0010
210 LUNG ADENOCARCINOMA 3 0.0010
211 PROSTATITIS 3 0.0010
212 DIVERTICULUM 7 0.0010
213 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
214 PANCREATIC CARCINOMA 28 0.0010
215 CHOLANGITIS 6 0.0010
216 PANCREATIC CARCINOMA STAGE IV 3 0.0010
217 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
218 DRUG-INDUCED LIVER INJURY 29 0.0009
219 HEPATITIS ACUTE 6 0.0009
220 HYPERKALAEMIA 32 0.0009
221 ILEUS PARALYTIC 4 0.0009
222 AFFECTIVE DISORDER 7 0.0009
223 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
224 CHRONIC GASTRITIS 2 0.0009
225 RENAL CYST 7 0.0009
226 HYPERGLYCAEMIA 32 0.0009
227 SYNOVIAL CYST 4 0.0009
228 LARGE INTESTINE PERFORATION 6 0.0009
229 ESCHERICHIA BACTERAEMIA 2 0.0008
230 JAUNDICE CHOLESTATIC 3 0.0008
231 PULMONARY TOXICITY 6 0.0008
232 SPINAL COMPRESSION FRACTURE 7 0.0008
233 COLITIS MICROSCOPIC 4 0.0008
234 CARDIAC TAMPONADE 4 0.0008
235 NEUTROPENIC SEPSIS 6 0.0008
236 ANGINA PECTORIS 24 0.0008
237 RASH VESICULAR 4 0.0008
238 DIZZINESS POSTURAL 8 0.0008
239 ACUTE MYOCARDIAL INFARCTION 24 0.0008
240 HEPATIC STEATOSIS 15 0.0008
241 CHEMICAL BURN OF SKIN 2 0.0008
242 CLAVICLE FRACTURE 3 0.0008
243 CANCER PAIN 2 0.0008
244 PHYSICAL DECONDITIONING 2 0.0008
245 MELAENA 17 0.0008
246 HYPOALBUMINAEMIA 6 0.0008
247 ANGINA UNSTABLE 5 0.0008
248 RHABDOMYOLYSIS 32 0.0008
249 GASTRIC CANCER 19 0.0007
250 BLOOD SODIUM INCREASED 2 0.0007
251 METASTASES TO LYMPH NODES 5 0.0007
252 RED BLOOD CELL COUNT INCREASED 2 0.0007
253 DIABETES MELLITUS 55 0.0007
254 EOSINOPHIL COUNT INCREASED 6 0.0007
255 ELECTRIC SHOCK SENSATION 2 0.0007
256 ENDOTRACHEAL INTUBATION 2 0.0007
257 GENERALISED ERYTHEMA 4 0.0007
258 PULMONARY TUBERCULOSIS 3 0.0007
259 TOXIC SKIN ERUPTION 7 0.0007
260 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
261 COMA SCALE ABNORMAL 2 0.0007
262 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
263 HAEMORRHAGIC ANAEMIA 3 0.0007
264 STEVENS-JOHNSON SYNDROME 15 0.0007
265 BLOOD IRON DECREASED 8 0.0007
266 HEPATITIS FULMINANT 2 0.0007
267 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
268 KETOACIDOSIS 5 0.0007
269 URINARY TRACT DISORDER 3 0.0007
270 GANGRENE 4 0.0007
271 ACUTE KIDNEY INJURY 101 0.0007
272 ADRENAL INSUFFICIENCY 8 0.0007
273 DYSCHEZIA 2 0.0007
274 PNEUMONIA BACTERIAL 6 0.0007
275 INTRACARDIAC THROMBUS 2 0.0007
276 MENISCUS INJURY 4 0.0006
277 HYPOKALAEMIA 30 0.0006
278 CARDIAC FAILURE 52 0.0006
279 PHARYNGITIS 8 0.0006
280 HEPATIC ENCEPHALOPATHY 6 0.0006
281 RENAL IMPAIRMENT 54 0.0006
282 PNEUMONIA ASPIRATION 16 0.0006
283 BLOOD GLUCOSE FLUCTUATION 7 0.0006
284 SPINAL COLUMN STENOSIS 3 0.0006
285 ANGIOEDEMA 28 0.0006
286 NON-CARDIAC CHEST PAIN 2 0.0006
287 RIB FRACTURE 13 0.0006
288 MUSCLE ATROPHY 8 0.0006
289 POLYMYALGIA RHEUMATICA 2 0.0006
290 BILE DUCT STONE 2 0.0006
291 MYASTHENIA GRAVIS 5 0.0006
292 GASTROENTERITIS 9 0.0006
293 BLOOD POTASSIUM INCREASED 10 0.0006
294 MYOCARDIAL ISCHAEMIA 7 0.0006
295 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
296 INFLAMMATORY BOWEL DISEASE 6 0.0006
297 HEPATIC NEOPLASM 2 0.0006
298 PANCREATIC DISORDER 3 0.0006
299 HYPERVOLAEMIA 3 0.0006
300 PHOTOSENSITIVITY REACTION 10 0.0006
301 ORGANISING PNEUMONIA 3 0.0006
302 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
303 EXPOSURE DURING BREAST FEEDING 2 0.0006
304 PEPTIC ULCER 2 0.0006
305 NEPHRITIS 2 0.0006
306 SUBARACHNOID HAEMORRHAGE 6 0.0006
307 EAR DISCOMFORT 6 0.0006
308 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
309 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
310 HEPATIC FIBROSIS 2 0.0006
311 BLOOD CREATININE INCREASED 38 0.0006
312 LEFT VENTRICULAR FAILURE 2 0.0006
313 BLOOD CREATININE ABNORMAL 2 0.0006
314 VENTRICULAR EXTRASYSTOLES 6 0.0006
315 CELLULITIS 29 0.0006
316 BLOOD LACTIC ACID INCREASED 3 0.0006
317 HYPONATRAEMIA 32 0.0006
318 FULL BLOOD COUNT ABNORMAL 6 0.0006
319 SINUS TACHYCARDIA 8 0.0006
320 HAEMORRHAGIC DIATHESIS 2 0.0006
321 COMPRESSION FRACTURE 3 0.0006
322 SUBDURAL HAEMATOMA 8 0.0006
323 ANAL ABSCESS 3 0.0006
324 DERMATITIS BULLOUS 4 0.0006
325 ASCITES 16 0.0005
326 IRON DEFICIENCY ANAEMIA 5 0.0005
327 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
328 CARDIAC DYSFUNCTION 2 0.0005
329 CHOLECYSTITIS ACUTE 3 0.0005
330 FACE INJURY 2 0.0005
331 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
332 LIVER DISORDER 23 0.0005
333 STRESS CARDIOMYOPATHY 3 0.0005
334 IMPAIRED GASTRIC EMPTYING 7 0.0005
335 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
336 EPIGASTRIC DISCOMFORT 2 0.0005
337 HEPATOMEGALY 5 0.0005
338 PLATELET COUNT DECREASED 54 0.0005
339 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
340 THIRST 9 0.0005
341 GOUT 9 0.0005
342 MUSCLE HAEMORRHAGE 2 0.0005
343 HYPOTHERMIA 5 0.0005
344 SHOCK HAEMORRHAGIC 4 0.0005
345 NEUTROPHIL COUNT DECREASED 20 0.0005
346 PERIPHERAL ISCHAEMIA 2 0.0005
347 POLYURIA 4 0.0005
348 CHOLELITHIASIS 16 0.0005
349 IMPAIRED QUALITY OF LIFE 7 0.0005
350 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
351 ANAPHYLACTOID REACTION 2 0.0005
352 POOR VENOUS ACCESS 5 0.0005
353 AORTIC DISSECTION 2 0.0005
354 COAGULOPATHY 8 0.0005
355 INTESTINAL OBSTRUCTION 18 0.0005
356 BREAST PAIN 5 0.0005
357 ORTHOSTATIC HYPOTENSION 8 0.0005
358 HEART RATE DECREASED 16 0.0005
359 GROIN PAIN 4 0.0005
360 PARONYCHIA 2 0.0005
361 PURPURA 4 0.0005
362 SWOLLEN TONGUE 14 0.0004
363 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
364 BLOOD GLUCOSE INCREASED 84 0.0004
365 BONE MARROW FAILURE 9 0.0004
366 OEDEMA 24 0.0004
367 SCIATICA 7 0.0004
368 HAEMOGLOBIN INCREASED 2 0.0004
369 NEPHROTIC SYNDROME 3 0.0004
370 DISEASE COMPLICATION 2 0.0004
371 NEOPLASM 5 0.0004
372 BLOOD GLUCOSE ABNORMAL 8 0.0004
373 GASTRITIS EROSIVE 2 0.0004
374 DEFAECATION URGENCY 3 0.0004
375 PAPULE 3 0.0004
376 DRUG LEVEL INCREASED 7 0.0004
377 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
378 BACTERAEMIA 5 0.0004
379 CHRONIC KIDNEY DISEASE 32 0.0004
380 BLOOD UREA INCREASED 7 0.0004
381 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
382 PARAESTHESIA ORAL 6 0.0004
383 FACE OEDEMA 7 0.0004
384 HUMERUS FRACTURE 2 0.0004
385 GUILLAIN-BARRE SYNDROME 2 0.0004
386 MENTAL IMPAIRMENT 10 0.0004
387 EAR PAIN 8 0.0004
388 PLEURAL EFFUSION 25 0.0004
389 JAUNDICE 11 0.0004
390 RENAL TUBULAR NECROSIS 4 0.0004
391 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
392 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
393 RASH MACULO-PAPULAR 9 0.0004
394 GENERALISED OEDEMA 5 0.0004
395 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
396 HYPERNATRAEMIA 2 0.0004
397 HYDRONEPHROSIS 3 0.0004
398 HYPERAMMONAEMIA 2 0.0004
399 DERMATITIS EXFOLIATIVE 2 0.0004
400 SECRETION DISCHARGE 5 0.0004
401 EMPHYSEMA 4 0.0004
402 PRODUCT AVAILABILITY ISSUE 9 0.0004
403 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
404 CORONARY ARTERIAL STENT INSERTION 2 0.0004
405 FEEDING DISORDER 8 0.0004
406 AORTIC ANEURYSM 3 0.0004
407 AMMONIA INCREASED 2 0.0004
408 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
409 SKIN ULCER 10 0.0004
410 TORSADE DE POINTES 3 0.0004
411 FOOD CRAVING 2 0.0004
412 IMMUNE SYSTEM DISORDER 5 0.0004
413 TOOTH INFECTION 5 0.0004
414 SARS-COV-2 TEST POSITIVE 5 0.0004
415 ANAL FISTULA 2 0.0004
416 RHINITIS 3 0.0004
417 GINGIVITIS 2 0.0004
418 FRACTURE 7 0.0004
419 FAECES DISCOLOURED 8 0.0004
420 PROTEINURIA 7 0.0004
421 PRODUCT DISPENSING ERROR 8 0.0004
422 HICCUPS 3 0.0004
423 ASPIRATION 4 0.0004
424 LUNG NEOPLASM MALIGNANT 15 0.0004
425 RENAL DISORDER 17 0.0004
426 OSTEONECROSIS OF JAW 9 0.0004
427 DIVERTICULITIS 10 0.0004
428 HEMIPLEGIA 3 0.0004
429 LIP SWELLING 12 0.0004
430 GASTROOESOPHAGEAL REFLUX DISEASE 29 0.0004
431 NECROSIS 2 0.0004
432 HYPOMAGNESAEMIA 5 0.0004
433 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
434 RASH PAPULAR 8 0.0004
435 BLOOD CALCIUM DECREASED 4 0.0004
436 HAEMATEMESIS 9 0.0004
437 SEASONAL ALLERGY 5 0.0004
438 FACIAL PARALYSIS 3 0.0004
439 UPPER LIMB FRACTURE 7 0.0004
440 SCAB 4 0.0004
441 MYOCARDITIS 4 0.0003
442 DECREASED APPETITE 80 0.0003
443 EYELID OEDEMA 4 0.0003
444 LIVER FUNCTION TEST ABNORMAL 10 0.0003
445 HYPOVOLAEMIA 2 0.0003
446 HYPERTRIGLYCERIDAEMIA 2 0.0003
447 SPLENOMEGALY 4 0.0003
448 NIGHT SWEATS 11 0.0003
449 SPINAL PAIN 4 0.0003
450 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
451 LYMPHOCYTE COUNT DECREASED 6 0.0003
452 ENERGY INCREASED 2 0.0003
453 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
454 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
455 PULMONARY MASS 5 0.0003
456 CEREBRAL HAEMORRHAGE 12 0.0003
457 FLATULENCE 19 0.0003
458 ROAD TRAFFIC ACCIDENT 14 0.0003
459 LEUKOCYTOSIS 6 0.0003
460 OSTEOMYELITIS 6 0.0003
461 DEHYDRATION 44 0.0003
462 DRUG DISPENSING ERROR 5 0.0003
463 OVARIAN CANCER 3 0.0003
464 CARDIOMEGALY 4 0.0003
465 UROSEPSIS 3 0.0003
466 POOR QUALITY SLEEP 7 0.0003
467 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
468 PIGMENTATION DISORDER 2 0.0003
469 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
470 EYE SWELLING 12 0.0003
471 OLIGURIA 2 0.0003
472 APPENDICITIS 3 0.0003
473 BLOOD SODIUM DECREASED 6 0.0003
474 DERMATITIS ALLERGIC 4 0.0003
475 PNEUMOTHORAX 5 0.0003
476 FOREIGN BODY SENSATION IN EYES 2 0.0003
477 HYPOTHYROIDISM 10 0.0003
478 PULMONARY FIBROSIS 6 0.0003
479 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
480 CHOLESTASIS 6 0.0003
481 SNEEZING 7 0.0003
482 ACUTE RESPIRATORY FAILURE 6 0.0003
483 PROCTALGIA 2 0.0003
484 CHROMATURIA 7 0.0003
485 HERPES SIMPLEX 2 0.0003
486 ASPERGILLUS INFECTION 2 0.0003
487 SHOCK 7 0.0003
488 MANIA 5 0.0003
489 PULMONARY CONGESTION 4 0.0003
490 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
491 CONSTIPATION 66 0.0003
492 MENINGITIS 2 0.0003
493 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
494 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
495 BRONCHIECTASIS 2 0.0003
496 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
497 DRUG LEVEL DECREASED 3 0.0003
498 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
499 BLOOD TESTOSTERONE DECREASED 2 0.0003
500 PERIPHERAL COLDNESS 4 0.0003
501 RESPIRATION ABNORMAL 2 0.0003
502 JOINT EFFUSION 2 0.0003
503 HYPERBILIRUBINAEMIA 3 0.0003
504 HAIR GROWTH ABNORMAL 2 0.0003
505 ANAEMIA 55 0.0003
506 PULMONARY HYPERTENSION 6 0.0003
507 PRODUCT ODOUR ABNORMAL 3 0.0003
508 BLOOD PRESSURE DECREASED 19 0.0003
509 BRADYCARDIA 15 0.0003
510 RENAL FAILURE ACUTE 12 0.0003
511 HAND FRACTURE 2 0.0003
512 METABOLIC ACIDOSIS 9 0.0003
513 RETINAL HAEMORRHAGE 2 0.0003
514 HALLUCINATION 21 0.0003
515 DECREASED ACTIVITY 3 0.0003
516 ATRIAL FIBRILLATION 27 0.0003
517 HYPERTHYROIDISM 4 0.0003
518 C-REACTIVE PROTEIN INCREASED 10 0.0003
519 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
520 END STAGE RENAL DISEASE 5 0.0003
521 MOUTH HAEMORRHAGE 2 0.0003
522 PSYCHIATRIC SYMPTOM 2 0.0003
523 VISUAL ACUITY REDUCED 9 0.0003
524 ARTHROPOD BITE 2 0.0003
525 MEDICATION ERROR 15 0.0003
526 ECZEMA 14 0.0003
527 HEPATIC CIRRHOSIS 5 0.0003
528 MITRAL VALVE INCOMPETENCE 3 0.0003
529 STOMATITIS 16 0.0003
530 FOOT FRACTURE 5 0.0003
531 SLEEP APNOEA SYNDROME 5 0.0003
532 HERPES ZOSTER 15 0.0003
533 PNEUMONIA 84 0.0003
534 BLOOD BILIRUBIN INCREASED 7 0.0003
535 FREQUENT BOWEL MOVEMENTS 7 0.0003
536 ATRIOVENTRICULAR BLOCK 2 0.0003
537 ERUCTATION 5 0.0003
538 FLUID RETENTION 13 0.0003
539 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
540 FURUNCLE 2 0.0003
541 CATARACT 15 0.0003
542 HYPERLIPIDAEMIA 3 0.0003
543 SEPSIS 28 0.0003
544 BLOOD GLUCOSE DECREASED 12 0.0002
545 CYTOKINE RELEASE SYNDROME 5 0.0002
546 NOCTURIA 3 0.0002
547 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
548 MUSCLE DISORDER 2 0.0002
549 MUSCLE TIGHTNESS 4 0.0002
550 SCHIZOPHRENIA 3 0.0002
551 PEMPHIGUS 3 0.0002
552 NEPHROLITHIASIS 11 0.0002
553 HAEMODIALYSIS 2 0.0002
554 HYPOPHAGIA 6 0.0002
555 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
556 VOMITING 110 0.0002
557 PSEUDOMONAS INFECTION 2 0.0002
558 ANURIA 2 0.0002
559 PRURITUS GENERALISED 5 0.0002
560 MUSCLE STRAIN 2 0.0002
561 DELIRIUM 8 0.0002
562 PRODUCTIVE COUGH 11 0.0002
563 CONDITION AGGRAVATED 70 0.0002
564 RASH ERYTHEMATOUS 11 0.0002
565 EPILEPSY 7 0.0002
566 EOSINOPHILIA 4 0.0002
567 BEDRIDDEN 3 0.0002
568 ORAL CANDIDIASIS 3 0.0002
569 HYPERTENSION 48 0.0002
570 LOSS OF CONSCIOUSNESS 29 0.0002
571 FEMUR FRACTURE 7 0.0002
572 EAR INFECTION 6 0.0002
573 PYREXIA 78 0.0002
574 LUNG DISORDER 11 0.0002
575 RASH 97 0.0002
576 DYSPHONIA 13 0.0002
577 THROAT TIGHTNESS 6 0.0002
578 GASTROENTERITIS VIRAL 4 0.0002
579 PERIPHERAL SWELLING 34 0.0002
580 LUPUS-LIKE SYNDROME 2 0.0002
581 PALLOR 6 0.0002
582 RESTLESS LEGS SYNDROME 4 0.0002
583 VISION BLURRED 30 0.0002
584 CONTUSION 21 0.0002
585 CARDIAC ARREST 18 0.0002
586 ORAL DISCOMFORT 3 0.0002
587 APHONIA 3 0.0002
588 ABDOMINAL PAIN 50 0.0002
589 NEPHROPATHY 2 0.0002
590 BLISTER 12 0.0002
591 EYE PAIN 12 0.0002
592 ABORTION INDUCED 2 0.0002
593 DYSPNOEA EXERTIONAL 8 0.0002
594 MALAISE 93 0.0002
595 LEUKAEMIA 2 0.0002
596 CARDIAC FAILURE CONGESTIVE 17 0.0002
597 GASTRIC ULCER 4 0.0002
598 NEUROPATHY PERIPHERAL 20 0.0002
599 FUNGAL INFECTION 7 0.0002
600 RED BLOOD CELL COUNT DECREASED 6 0.0002
601 URINARY RETENTION 7 0.0002
602 ABDOMINAL DISCOMFORT 35 0.0002
603 BLOOD PRESSURE FLUCTUATION 5 0.0002
604 HEPATIC CANCER 5 0.0002
605 MYELODYSPLASTIC SYNDROME 3 0.0002
606 ATELECTASIS 2 0.0002
607 SEPTIC SHOCK 9 0.0002
608 DIARRHOEA 133 0.0002
609 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
610 ORAL HERPES 4 0.0002
611 PHARYNGEAL SWELLING 2 0.0002
612 BLADDER CANCER 12 0.0002
613 PRURITUS 78 0.0002
614 SKIN HAEMORRHAGE 3 0.0002
615 IMMUNODEFICIENCY 3 0.0002
616 BLOOD PRESSURE ABNORMAL 4 0.0002
617 TREATMENT NONCOMPLIANCE 11 0.0002
618 BLOOD POTASSIUM DECREASED 6 0.0002
619 HEPATIC FAILURE 6 0.0002
620 LACRIMATION INCREASED 6 0.0002
621 FALL 66 0.0002
622 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
623 LYMPHADENOPATHY 7 0.0002
624 EYELID PTOSIS 2 0.0002
625 DRY THROAT 2 0.0002
626 MOTOR DYSFUNCTION 2 0.0002
627 BLOOD PRESSURE INCREASED 30 0.0002
628 DEVICE RELATED INFECTION 3 0.0002
629 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
630 ERECTILE DYSFUNCTION 5 0.0002
631 HELICOBACTER INFECTION 2 0.0002
632 MUSCULOSKELETAL CHEST PAIN 3 0.0002
633 LUNG INFECTION 3 0.0002
634 EYE DISCHARGE 2 0.0002
635 FOLLICULITIS 2 0.0002
636 HYPOTENSION 38 0.0002
637 INCONTINENCE 2 0.0002
638 HALLUCINATION, AUDITORY 3 0.0002
639 OEDEMA PERIPHERAL 23 0.0002
640 RENAL PAIN 2 0.0002
641 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
642 CYSTITIS 6 0.0002
643 EATING DISORDER 4 0.0002
644 BODY HEIGHT DECREASED 2 0.0002
645 MOVEMENT DISORDER 6 0.0002
646 RHINORRHOEA 12 0.0002
647 SWELLING FACE 12 0.0002
648 SLEEP DISORDER 13 0.0002
649 PNEUMONITIS 5 0.0002
650 DYSPEPSIA 18 0.0002
651 COVID-19 32 0.0002
652 DISCOMFORT 11 0.0002
653 GAIT INABILITY 6 0.0002
654 PALPITATIONS 21 0.0002
655 MALNUTRITION 2 0.0002
656 GASTROINTESTINAL DISORDER 16 0.0002
657 RESPIRATORY FAILURE 13 0.0002
658 INTESTINAL PERFORATION 2 0.0002
659 OCULAR DISCOMFORT 2 0.0002
660 FISTULA 2 0.0002
661 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
662 CANDIDA INFECTION 3 0.0002
663 ANGER 6 0.0002
664 DRUG INTERACTION 28 0.0002
665 URINARY TRACT INFECTION 30 0.0002
666 DERMATITIS CONTACT 2 0.0002
667 HAEMATURIA 6 0.0002
668 ERYTHEMA 36 0.0002
669 MICTURITION URGENCY 2 0.0002
670 INTERNAL HAEMORRHAGE 2 0.0002
671 COUGH 49 0.0002
672 MUSCULOSKELETAL DISCOMFORT 3 0.0002
673 JOINT SWELLING 21 0.0002
674 RENAL FAILURE 23 0.0002
675 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
676 WEIGHT DECREASED 48 0.0002
677 POST PROCEDURAL HAEMORRHAGE 2 0.0002
678 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
679 DEPRESSED MOOD 9 0.0002
680 COVID-19 PNEUMONIA 2 0.0002
681 DEEP VEIN THROMBOSIS 11 0.0002
682 ARRHYTHMIA 8 0.0002
683 ATAXIA 2 0.0002
684 DISEASE RECURRENCE 8 0.0002
685 PRODUCT PRESCRIBING ERROR 4 0.0002
686 ACCIDENT 2 0.0002
687 MUSCLE RIGIDITY 2 0.0002
688 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
689 MYOCARDIAL INFARCTION 29 0.0002
690 HAEMOGLOBIN DECREASED 17 0.0002
691 LOCALISED INFECTION 4 0.0002
692 NEURALGIA 4 0.0002
693 CONJUNCTIVITIS 3 0.0002
694 THROMBOSIS 13 0.0002
695 URTICARIA 27 0.0002
696 EXTRAPYRAMIDAL DISORDER 4 0.0002
697 PANCYTOPENIA 9 0.0002
698 NECK PAIN 9 0.0002
699 BACTERIAL INFECTION 3 0.0002
700 AGEUSIA 4 0.0002
701 HYPOAESTHESIA 24 0.0002
702 BONE DENSITY DECREASED 5 0.0002
703 PHOTOPHOBIA 3 0.0002
704 BLOOD URINE PRESENT 3 0.0002
705 FEELING JITTERY 3 0.0002
706 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
707 LOWER LIMB FRACTURE 3 0.0002
708 INTENTIONAL OVERDOSE 10 0.0002
709 GLAUCOMA 3 0.0002
710 THERAPY NON-RESPONDER 7 0.0002
711 NAUSEA 123 0.0002
712 PRESCRIBED OVERDOSE 3 0.0002
713 RASH GENERALISED 4 0.0002
714 DIZZINESS 77 0.0002
715 ABDOMINAL DISTENSION 16 0.0002
716 NERVOUSNESS 8 0.0002
717 MEMORY IMPAIRMENT 21 0.0002
718 DYSPNOEA 86 0.0002
719 WHEEZING 9 0.0002
720 HEART RATE INCREASED 15 0.0002
721 SKIN DISORDER 5 0.0001
722 EYE HAEMORRHAGE 2 0.0001
723 SWELLING 14 0.0001
724 PRODUCT ADMINISTRATION ERROR 3 0.0001
725 DISTURBANCE IN ATTENTION 8 0.0001
726 TASTE DISORDER 3 0.0001
727 OCULAR HYPERAEMIA 7 0.0001
728 AKATHISIA 2 0.0001
729 NASOPHARYNGITIS 27 0.0001
730 GINGIVAL BLEEDING 2 0.0001
731 CORONARY ARTERY OCCLUSION 2 0.0001
732 SKIN LESION 4 0.0001
733 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
734 PERITONITIS 3 0.0001
735 ARTHRALGIA 60 0.0001
736 ARTHROPATHY 8 0.0001
737 POLLAKIURIA 6 0.0001
738 HUNGER 2 0.0001
739 CARDIO-RESPIRATORY ARREST 6 0.0001
740 HAEMOPTYSIS 4 0.0001
741 CARPAL TUNNEL SYNDROME 2 0.0001
742 PAIN IN EXTREMITY 42 0.0001
743 BLOOD TEST ABNORMAL 2 0.0001
744 SKIN EXFOLIATION 12 0.0001
745 HYPOXIA 5 0.0001
746 BLINDNESS UNILATERAL 2 0.0001
747 DIALYSIS 2 0.0001
748 ABDOMINAL PAIN UPPER 29 0.0001
749 MUSCULAR WEAKNESS 16 0.0001
750 INTENTIONAL DOSE OMISSION 4 0.0001
751 PARALYSIS 2 0.0001
752 CARDIOGENIC SHOCK 2 0.0001
753 HYPOACUSIS 6 0.0001
754 NO ADVERSE EVENT 25 0.0001
755 MENTAL DISORDER 6 0.0001
756 HYPOKINESIA 2 0.0001
757 NEEDLE ISSUE 4 0.0001
758 VISUAL IMPAIRMENT 17 0.0001
759 DYSSTASIA 4 0.0001
760 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
761 MUSCULOSKELETAL STIFFNESS 12 0.0001
762 RESTLESSNESS 5 0.0001
763 MUSCLE SPASMS 25 0.0001
764 INFUSION RELATED REACTION 9 0.0001
765 LABORATORY TEST ABNORMAL 4 0.0001
766 CARDIOMYOPATHY 2 0.0001
767 CHEST PAIN 25 0.0001
768 HEPATOTOXICITY 3 0.0001
769 RENAL INJURY 4 0.0001
770 RESPIRATORY DISORDER 4 0.0001
771 ANXIETY 38 0.0001
772 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
773 DYSARTHRIA 5 0.0001
774 HEART RATE IRREGULAR 3 0.0001
775 APHASIA 4 0.0001
776 BLOOD COUNT ABNORMAL 2 0.0001
777 SKIN DISCOLOURATION 6 0.0001
778 CEREBROVASCULAR ACCIDENT 22 0.0001
779 LYMPHOMA 2 0.0001
780 HYPERSENSITIVITY 24 0.0001
781 ANKLE FRACTURE 2 0.0001
782 RASH PRURITIC 7 0.0001
783 BACK PAIN 30 0.0001
784 DELUSION 2 0.0001
785 BLOOD CHOLESTEROL INCREASED 6 0.0001
786 BASAL CELL CARCINOMA 2 0.0001
787 FLUSHING 13 0.0001
788 PRODUCT USE COMPLAINT 2 0.0001
789 HAEMATOCHEZIA 7 0.0001
790 ANAPHYLACTIC REACTION 7 0.0001
791 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
792 RESPIRATORY TRACT CONGESTION 2 0.0001
793 INFLUENZA 14 0.0001
794 OBESITY 2 0.0001
795 TOXICITY TO VARIOUS AGENTS 21 0.0001
796 PROSTATE CANCER 10 0.0001
797 HOSPITALISATION 19 0.0001
798 DRY MOUTH 10 0.0001
799 LIVER INJURY 3 0.0001
800 METASTASES TO BONE 2 0.0001
801 FEBRILE NEUTROPENIA 8 0.0001
802 TREMOR 20 0.0001
803 CYTOMEGALOVIRUS INFECTION 2 0.0001
804 EPISTAXIS 9 0.0001
805 NEOPLASM MALIGNANT 8 0.0001
806 EYE PRURITUS 4 0.0001
807 OROPHARYNGEAL PAIN 11 0.0001
808 DEPRESSION 27 0.0001
809 ABDOMINAL PAIN LOWER 3 0.0001
810 HEMIPARESIS 2 0.0001
811 MYALGIA 20 0.0001
812 CHEST DISCOMFORT 12 0.0001
813 ASTHENIA 44 0.0001
814 THERAPY CESSATION 6 0.0001
815 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
816 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
817 HYPERHIDROSIS 15 0.0001
818 ANAPHYLACTIC SHOCK 3 0.0001
819 HAEMATOMA 3 0.0001
820 RESPIRATORY TRACT INFECTION 3 0.0001
821 ASTHMA 13 0.0001
822 VERTIGO 7 0.0001
823 MUSCULOSKELETAL PAIN 6 0.0001
824 DEVICE USE ISSUE 2 0.0001
825 ANHEDONIA 3 0.0001
826 GASTRITIS 3 0.0001
827 METASTASES TO LIVER 2 0.0001
828 COLD SWEAT 2 0.0001
829 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
830 HEAD DISCOMFORT 2 0.0001
831 INSOMNIA 30 0.0001
832 ISCHAEMIC STROKE 2 0.0001
833 COLITIS ULCERATIVE 5 0.0001
834 PULMONARY OEDEMA 5 0.0001
835 HEADACHE 70 0.0001
836 THROAT IRRITATION 5 0.0001
837 MOBILITY DECREASED 8 0.0001
838 OVERDOSE 24 0.0001
839 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
840 LIMB INJURY 3 0.0001
841 DYSURIA 4 0.0001
842 FEELING COLD 3 0.0001
843 DEMENTIA 3 0.0001
844 WEIGHT INCREASED 24 0.0001
845 COGNITIVE DISORDER 5 0.0001
846 HYPOCALCAEMIA 2 0.0001
847 DYSPHAGIA 10 0.0001
848 PULMONARY EMBOLISM 10 0.0001
849 MUSCULOSKELETAL DISORDER 2 0.0001
850 HYPERSOMNIA 3 0.0001
851 FEELING ABNORMAL 25 0.0001
852 POST PROCEDURAL COMPLICATION 2 0.0001
853 DRUG PRESCRIBING ERROR 2 0.0001
854 INFECTION 15 0.0001
855 HAEMORRHOIDS 2 0.0001
856 CHOKING 2 0.0001
857 BONE PAIN 6 0.0001
858 SURGERY 6 0.0001
859 URINARY INCONTINENCE 3 0.0001
860 OESOPHAGEAL CARCINOMA 3 0.0001
861 HAEMATOCRIT DECREASED 2 0.0001
862 CORONARY ARTERY DISEASE 3 0.0001
863 SUICIDE ATTEMPT 6 0.0001
864 THROMBOCYTOPENIA 11 0.0001
865 SUICIDAL IDEATION 9 0.0001
866 BODY TEMPERATURE INCREASED 2 0.0001
867 FEELING HOT 6 0.0001
868 SINUSITIS 10 0.0001
869 OSTEOPOROSIS 4 0.0001
870 ILLNESS 10 0.0001
871 EXPOSURE DURING PREGNANCY 6 0.0001
872 NERVOUS SYSTEM DISORDER 3 0.0001
873 UNDERDOSE 7 0.0001
874 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
875 DERMATITIS 2 0.0001
876 MOUTH ULCERATION 2 0.0001
877 HEAD INJURY 3 0.0001
878 PAIN 58 0.0001
879 SOMNOLENCE 19 0.0001
880 DISEASE PROGRESSION 11 0.0001
881 FATIGUE 71 0.0001
882 APPLICATION SITE PAIN 2 0.0001
883 PRODUCT USE ISSUE 17 0.0001
884 VIRAL INFECTION 3 0.0001
885 TYPE 2 DIABETES MELLITUS 3 0.0001
886 PARAESTHESIA 14 0.0001
887 OXYGEN SATURATION DECREASED 5 0.0001
888 HEPATIC ENZYME INCREASED 6 0.0001
889 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
890 LETHARGY 5 0.0001
891 EYE IRRITATION 5 0.0001
892 NIGHTMARE 3 0.0001
893 CONFUSIONAL STATE 14 0.0001
894 SEIZURE 10 0.0001
895 NEOPLASM PROGRESSION 3 0.0001
896 INFLUENZA LIKE ILLNESS 7 0.0001
897 COMA 4 0.0001
898 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
899 OFF LABEL USE 73 0.0001
900 DRUG EFFECT INCOMPLETE 3 0.0001
901 DEATH 71 0.0001
902 FIBROMYALGIA 2 0.0001
903 ACCIDENTAL OVERDOSE 3 0.0001
904 AGITATION 6 0.0001
905 ENCEPHALOPATHY 2 0.0001
906 INJECTION SITE MASS 3 0.0001
907 BRONCHITIS 6 0.0001
908 DYSGEUSIA 6 0.0001
909 COLITIS 3 0.0001
910 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
911 DIPLOPIA 2 0.0001
912 PRODUCT DOSE OMISSION 5 0.0001
913 ABNORMAL BEHAVIOUR 3 0.0001
914 DYSKINESIA 3 0.0001
915 MOOD ALTERED 2 0.0001
916 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
917 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
918 OSTEOARTHRITIS 3 0.0001
919 RHEUMATOID ARTHRITIS 8 0.0001
920 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
921 SYNCOPE 7 0.0001
922 BALANCE DISORDER 6 0.0001
923 PRODUCT STORAGE ERROR 6 0.0001
924 CHILLS 8 0.0001
925 NASAL CONGESTION 4 0.0001
926 TACHYCARDIA 6 0.0001
927 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
928 ADVERSE DRUG REACTION 6 0.0001
929 IRRITABILITY 4 0.0001
930 EMOTIONAL DISORDER 2 0.0001
931 BREAST CANCER 6 0.0001
932 CARDIAC DISORDER 6 0.0001
933 ARTHRITIS 5 0.0001
934 MOOD SWINGS 2 0.0001
935 GAIT DISTURBANCE 12 0.0001
936 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
937 HIP FRACTURE 2 0.0001
938 ALOPECIA 12 0.0001
939 TREATMENT FAILURE 5 0.0001
940 DRY EYE 3 0.0001
941 AGGRESSION 3 0.0001
942 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
943 GASTRIC DISORDER 2 0.0001
944 DRUG INEFFECTIVE 76 0.0001
945 SPEECH DISORDER 3 0.0001
946 RASH MACULAR 2 0.0001
947 BURNING SENSATION 4 0.0001
948 INJURY 4 0.0001
949 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
950 PRODUCT ADHESION ISSUE 2 0.0001
951 MYELOSUPPRESSION 2 0.0001
952 CRYING 2 0.0001
953 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
954 PLASMA CELL MYELOMA 2 0.0001
955 PRODUCT DOSE OMISSION ISSUE 15 0.0001
956 EMOTIONAL DISTRESS 6 0.0000
957 THERAPEUTIC RESPONSE DECREASED 3 0.0000
958 HAEMORRHAGE 5 0.0000
959 RECTAL HAEMORRHAGE 2 0.0000
960 DEVICE LEAKAGE 2 0.0000
961 AMNESIA 3 0.0000
962 PSORIASIS 6 0.0000
963 NEUTROPENIA 6 0.0000
964 RENAL CANCER 2 0.0000
965 THERAPY INTERRUPTED 3 0.0000
966 MULTIPLE SCLEROSIS 2 0.0000
967 DRUG INTOLERANCE 4 0.0000
968 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
969 LEUKOPENIA 2 0.0000
970 UNEVALUABLE EVENT 3 0.0000
971 INFLAMMATION 2 0.0000
972 PRODUCT SUBSTITUTION ISSUE 2 0.0000
973 INTENTIONAL PRODUCT MISUSE 3 0.0000
974 DEVICE ISSUE 3 0.0000
975 ADVERSE EVENT 3 0.0000
976 INCORRECT DOSE ADMINISTERED 7 0.0000
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
978 HOT FLUSH 2 0.0000
979 ACNE 2 0.0000
980 DRUG DOSE OMISSION 4 0.0000
981 DRY SKIN 3 0.0000
982 PRODUCT QUALITY ISSUE 3 0.0000
983 MIGRAINE 2 0.0000
984 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
985 INJECTION SITE PAIN 5 0.0000
986 INJECTION SITE ERYTHEMA 2 0.0000